Akynzeo® IV Concentrate for Solution for Infusion 235 mg/0.25 mg/vial
Product details
Registration number: SIN16899P
Classification: Prescription Only
Active ingredients:
- Fosnetupitant Chloride Hydrochloride equivalent to Fosnetupitant
- Palonosetron hydrochloride equivalent to Palonosetron
Strength:
- 235mg/vial
- 0.25 mg/vial
Dosage form: INFUSION, SOLUTION CONCENTRATE
Route: INTRAVENOUS
Registrant: JUNIPER BIOLOGICS PTE LTD
ATC code: A04AA55
HSA approval date: 28 November 2023
Manufacturer(s): Simtra Deutschland GmbH
Manufacturing country/countries: GERMANY
What are the HSA registration number and classification for Akynzeo® IV Concentrate for Solution for Infusion 235 mg/0.25 mg/vial?
According to the HSA dataset updated 7 August 2026:
Registration number: SIN16899P
Classification: Prescription Only
What active ingredients and strength are recorded for Akynzeo® IV Concentrate for Solution for Infusion 235 mg/0.25 mg/vial?
According to the HSA dataset updated 7 August 2026:
Active ingredients:
- Fosnetupitant Chloride Hydrochloride equivalent to Fosnetupitant
- Palonosetron hydrochloride equivalent to Palonosetron
Strength:
- 235mg/vial
- 0.25 mg/vial
Ingredients and strengths are listed separately as recorded by HSA; their positions do not establish a one-to-one match. This is not a dosing instruction.
What dosage form and route are recorded for Akynzeo® IV Concentrate for Solution for Infusion 235 mg/0.25 mg/vial?
According to the HSA dataset updated 7 August 2026:
Dosage form: INFUSION, SOLUTION CONCENTRATE
Route: INTRAVENOUS
Who is the recorded registrant for Akynzeo® IV Concentrate for Solution for Infusion 235 mg/0.25 mg/vial?
According to the HSA dataset updated 7 August 2026:
Registrant: JUNIPER BIOLOGICS PTE LTD
Which manufacturers and countries are listed for Akynzeo® IV Concentrate for Solution for Infusion 235 mg/0.25 mg/vial?
According to the HSA dataset updated 7 August 2026:
Manufacturer(s): Simtra Deutschland GmbH
Manufacturing country/countries: GERMANY
Where can I look up Akynzeo® IV Concentrate for Solution for Infusion 235 mg/0.25 mg/vial in the HSA register?
Open HSA’s therapeutic product register and search for registration number SIN16899P or the exact product name Akynzeo® IV Concentrate for Solution for Infusion 235 mg/0.25 mg/vial. The general register link does not preselect this product.
What are the source dates for this Akynzeo® IV Concentrate for Solution for Infusion 235 mg/0.25 mg/vial record?
This record is from HSA’s List of Registered Therapeutic Products on data.gov.sg. Dataset update: 7 August 2026. Retrieval date: 13 November 2026.
The dataset date is a snapshot date, not a separate current-register check for every product. Later direct checks are recorded separately.
Has this Akynzeo® IV Concentrate for Solution for Infusion 235 mg/0.25 mg/vial record had a separate HSA register check?
No separate current-register check is recorded for this product. Its presence in the imported dataset does not establish its current registration status.
Search the HSA register using SIN16899P for the latest record.
Sources and dates
HSA dataset: 2026. Updated: 13 November 2026.
Factual product information only; no dosing, treatment or suitability advice.
Updated and reviewed by: Dr Joel Lim MBChB UK (PG Dip Dermatology), Resident Physician.
.png)